Vidwan-ID : 430703



  • Prof Gopal Natesan

  • Professor
  • Institute of Pharmacy, Nirma University
Publications 1996 - 2024

Publications

  • 43
    Journal Articles
  • 2
    Conference
    Proceedings
  • 7
    Projects

Google Scholar

Co-author Network


Expertise

Medicinal Chemistry

Medicinal Chemsitry, Phytochemistry

Personal Information

Prof Gopal Natesan

Male
Institute of Pharmacy SG Highway, Sola, Ahmedabad, Gujarat, India
Ahmedabad, Gujarat, India - 382481


Experience

  • Professor

    Department of Pharmacy

    Institute of Pharmacy, Nirma University


Qualification

  • MBA

    MAHSA University, Malaysia

  • Post Graduate Certificate in T & L in Higher Education

    Anglia Ruskin University, UK

  • Ph D

    Jamia Hamdard


Honours and Awards

2023

MOST TRUSTED & INNOVATIVE RESEARCHERS IN ASIA

For Excellence & Leadership in Education in ASIA-GCC AWARD, organized by DYNERGIC Business Solution, 22nd July 2023.

2022

EDWARD KENNEDY MEMORIAL AWARD

2nd Global Cancer Summit 2017, 22nd – 24th March 2017, Shanghari-La Hotel, Kuala Lumpur, Malaysia.

2022

OUTSTANDING SCIENTIST AWARD

International Eminent Awards on Engineering, Science and Medicine.

Read More
2023

MOST TRUSTED & INNOVATIVE RESEARCHERS IN ASIA

For Excellence & Leadership in Education in ASIA-GCC AWARD, organized by DYNERGIC Business Solution, 22nd July 2023.

2022

EDWARD KENNEDY MEMORIAL AWARD

2nd Global Cancer Summit 2017, 22nd – 24th March 2017, Shanghari-La Hotel, Kuala Lumpur, Malaysia.

2022

OUTSTANDING SCIENTIST AWARD

International Eminent Awards on Engineering, Science and Medicine.

2022

VICE-CHANCELLOR AWARD

MAHSA University, Malaysia

2018

Best Presentation Award

International Conference on Biochemical Pharmacology and Medicinal Chemistry, Sydney, Australia.

2013

YOUNG SCIENTIST AWARD”

International Society for Nature and Health Care Inc. USA (ISNHC)

2006

Best Paper in the poster session

APTI

1997

Senior Research Fellowship

CSIR

Read Less

Doctoral Theses Guided

2017

Studies on novel Isatin Derivatives and some other Heterocyclic compounds as potential pharmacological agents.

Ms Meenakshi K, Jawaharlal Nehru Technological University Hyderabad

2014

Synthesis and biological evaluation of pyrazole derivatives and some other heterocyclic compounds

P Kumar Nallasivan, Vinayaka Missions Research Foundation

2013

Development of Chromatographic and Spectroscopic methods for the Estimation of Some Drugs.

Mr. Jagadeeswaran, Vinayaka Missions Research Foundation

Read More
2017

Studies on novel Isatin Derivatives and some other Heterocyclic compounds as potential pharmacological agents.

Ms Meenakshi K, Jawaharlal Nehru Technological University Hyderabad

2014

Synthesis and biological evaluation of pyrazole derivatives and some other heterocyclic compounds

P Kumar Nallasivan, Vinayaka Missions Research Foundation

2013

Development of Chromatographic and Spectroscopic methods for the Estimation of Some Drugs.

Mr. Jagadeeswaran, Vinayaka Missions Research Foundation

2012

Studies on Coumarin Derivatives & other Heterocyclic compounds

Ms. V N Indulatha, Vinayaka Missions Research Foundation

2012

Development & In-vitro/In-vivo Evaluation of Niosomes encapsulated antimicrobial drugs

Mr. Nethaji Ramalingam, Vinayaka Missions Research Foundation

2011

Synthesis & Pharmacological Investigation of Polyhydroxy Flavones and other substituted Flavones

Ms Lincy Joseph, Vinayaka Mission University, Salem, Tamil Nadu

Read Less

Membership In Professional Bodies

2023

Scholars Academic and Scientific Society (SAS) – An International Society for Academic and Scientific Integration

SAS Eminent Fellow Membership (SEFM), Life Membership No.: SAS/SEFM/201/2023

2018

Operant Pharmacy Federation, India

Life Membership No.: OPF/MEM/2018/LTM/036

2018

Malaysian Association of Cancer Research, Malaysia

Associate Membership No. A0005

Read More
2023

Scholars Academic and Scientific Society (SAS) – An International Society for Academic and Scientific Integration

SAS Eminent Fellow Membership (SEFM), Life Membership No.: SAS/SEFM/201/2023

2018

Operant Pharmacy Federation, India

Life Membership No.: OPF/MEM/2018/LTM/036

2018

Malaysian Association of Cancer Research, Malaysia

Associate Membership No. A0005

2009

InPharm Association (A Young Pharmacists’ Group of India)

Life Membership No.:264-PM-2009

2008

Association of Pharmacy Teachers of India (APTI)

Life Membership No.: AP/LM/285

2000

Indian Pharmaceutical Association (IPA)

Life Membership No.: DLH/LM/0364

1999

Registered Pharmacist, Tamil Nadu Pharmacy Council, Chennai, India.

Life Membership No.: 3714A1

1997

Indian Pharmacy Graduate Association (IPGA)

Life Membership No.: LM/980

Read Less

Membership In Committees

2023

SAS Eminent Fellow Membership (SEFM), Scholars Academic and Scientific Society (SAS) – An International Society for Academic and Scientific Integration.

Life Member

2018

Operant Pharmacy Federation, India.

Life Membership

2018

Malaysian Association of Cancer Research, Malaysia

Associate Membership

Read More
2023

SAS Eminent Fellow Membership (SEFM), Scholars Academic and Scientific Society (SAS) – An International Society for Academic and Scientific Integration.

Life Member

2018

Operant Pharmacy Federation, India.

Life Membership

2018

Malaysian Association of Cancer Research, Malaysia

Associate Membership

2000

Indian Pharmaceutical Association (IPA)

Life Member

1999

Tamil Nadu Pharmacy Council, Chennai, India

Registered Pharmacist, Life Member

1997

Indian Pharmacy Graduate Association (IPGA)

Life Member

Read Less

Research Projects

Inhibition of Cancer Cell Growth: By novel quinazolin-3(4H)-one targeting EGFR receptor

Funding Agency : MRCB George Kent Sdn Bhd (MRCB George Kent) with Prasarana Malaysia Bhd

Investigation of Novel 1-[1-(5-(substituted)-1,3,4-oxadiozol-2-yl) methyll-3-(4-substituted phenyl)-2-thioxo-2,3-dihydroquinazolin-4(3H)-one analogs as EGFR tyrosine kinase inhibitors.

Funding Agency : MAHSA University Research Fund

Synthesis & characterization of [1-(N-substituted amino) methyl]-2-[o-phenyl-(substituted benzylidene)] benzimidazole derivatives

Funding Agency : MAHSA University Research Fund

Read More

Inhibition of Cancer Cell Growth: By novel quinazolin-3(4H)-one targeting EGFR receptor

Funding Agency : MRCB George Kent Sdn Bhd (MRCB George Kent) with Prasarana Malaysia Bhd

Investigation of Novel 1-[1-(5-(substituted)-1,3,4-oxadiozol-2-yl) methyll-3-(4-substituted phenyl)-2-thioxo-2,3-dihydroquinazolin-4(3H)-one analogs as EGFR tyrosine kinase inhibitors.

Funding Agency : MAHSA University Research Fund

Synthesis & characterization of [1-(N-substituted amino) methyl]-2-[o-phenyl-(substituted benzylidene)] benzimidazole derivatives

Funding Agency : MAHSA University Research Fund

Studies on Quinazolinone derivatives and some other Heterocyclic compounds

Funding Agency : Council of Scientific and Industrial Research (CSIR), Government of India

Studies on Quinazolinone derivatives and some other Heterocyclic compounds

Funding Agency : CSIR

Testing and validation of Prototype for Cold Vaporized Hydrogen Peroxide Sterilization System

Funding Agency : harmalab India Pvt Ltd., India

Feasibility study of waste water treatment using non thermal plasma

Funding Agency : Board of Research in Nuclear Sciences

Read Less